SR 12813
Tocris Bioscience, part of Bio-Techne | Catalog # 2969
Pregnane X receptor agonist
Product Description
SR 12813 is a pregnane X receptor (PXR) agonist (EC50 values are 200 and 700 nM for human and rabbit PXR respectively). Activates the farnesoid X receptor (FXR) at μM concentrations. Displays hypocholesterolemic activity via enhanced degradation of HMG-CoA reductase.Product Specifications
Molecular Weight
504.53
Formula
C24H42O7P2
Storage
Store at +4°C
Purity
≥98% (HPLC)
Chemical Name
[[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]ethenylidene]bis-phosphonic acid tetraethyl ester
CAS Number
126411-39-0
PubChem ID
446313
InChI Key
YQLJDECYQDRSBI-UHFFFAOYSA-N
SMILES
OC1=C(C(C)(C)C)C=C(/C=C(P(OCC)(OCC)=O)/P(OCC)(OCC)=O)C=C1C(C)(C)C
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 50.45 | 100 | |
| Ethanol | 50.45 | 100 |
Preparing Stock Solutions
for SR 12813
The following data is based on the product molecular weight 504.53
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.98 mL | 9.91 mL | 19.82 mL |
| 5 mM | 0.40 mL | 1.98 mL | 3.96 mL |
| 10 mM | 0.20 mL | 0.99 mL | 1.98 mL |
| 50 mM | 0.04 mL | 0.20 mL | 0.40 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Lemaire Discovery of a highly active ligand of human pregnane X receptor: a case study from pharmacophore modeling and virtual screening to "in vivo" biological activity. Mol.Pharmacol. 2007 PMID: 17573484
- Jones The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol.Pharmacol.
- Berkhout The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase J.Biol.Chem. 1996 PMID: 8662919
Product Specific Notices for SR 12813
For research use only
Loading...
Loading...